STVN STVN

Stevanato Stock Price

15.52
-0.12 (-0.77%)
Upgrade to Real-Time
Afterhours (Closed)
15.52
Volume 409,504
Bid Price
Ask Price
News -
Day High 15.93

Low
13.355

52 Week Range

High
24.60

Day Low 14.93
Company Name Stock Ticker Symbol Market Type
Stevanato Group SpA STVN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -0.77% 15.52 16:00:16
Open Price Low Price High Price Close Price Prev Close
15.93 14.93 15.93 15.52 15.64
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,606 409,504 $ 15.53 $ 6,358,117 - 13.355 - 24.60
Last Trade Time Type Quantity Stock Price Currency
19:00:00 11,466 $ 15.52 USD

Period:

Draw Mode:

Stevanato Group SpA Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.11B 264.70M 33.07M $ 959.87M $ 145.32M 0.60 27.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.34% 06/13/22 - -

more financials information »

Stevanato News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical STVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.0016.2114.9315.54307,4500.523.47%
1 Month14.6116.2113.7114.87455,0830.916.23%
3 Months17.7519.4113.7116.21358,429-2.23-12.56%
6 Months16.5819.4113.7116.26319,054-1.06-6.39%
1 Year22.6324.6013.35517.26324,273-7.11-31.42%
3 Years16.6529.1813.35519.58406,470-1.13-6.79%
5 Years16.6529.1813.35519.58406,470-1.13-6.79%

Stevanato Description

Italy-based Stevanato Group is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% in South America.